Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1110964

registered interest
date	10/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Crohn's Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the change in the number of people diagnosed with Crohn's disease between 2008 and 2018.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	243360
answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>Information regarding number of patients diagnosed with Crohn’s disease in any one year is not available, and therefore no estimate has been made. The National Institute for Health and Care Excellence guidance, ‘Crohn’s disease: management’, updated in 2016 to reflect the last available evidence, states that at least 115,000 people in the United Kingdom have the condition.</p><p> </p><p>The guidance can be found at the following link:</p><p> </p><p><a href="http://www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085" target="_blank">www.nice.org.uk/guidance/cg152/resources/crohns-disease-management-pdf-35109627942085</a></p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 12:04:18 answering member 4455 label Biography information for Seema Kennedy previous answer version 114109 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1409 label Biography information for Mr Gregory Campbell

1110984

registered interest
date	10/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Urinary Tract Infections: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 5 April 2019 to Question 237733, what representations he has received on the capability of NHS urinary trace infection screening tests to detect bacteria hidden in the bladder's lining.
tabling member constituency	Tooting
tabling member printed	Dr Rosena Allin-Khan
uin	243537
answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>A search of the Department’s Ministerial correspondence database has identified four items of correspondence received on the capability of National Health Service urinary tract infection (UTI) screening tests to detect bacteria in the bladder's lining during the past 12 months. This figure represents correspondence received by the Department’s Ministerial correspondence unit only.</p><p>In November 2018 Public Health England published guidance on the diagnosis of UTIs. This guidance states that “no individual or combination (of symptoms or dipstick) are completely reliable in diagnosing UTI, thus severity of symptoms and safety-netting are important.”</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 12:22:09 answering member 4455 label Biography information for Seema Kennedy
tabling member	4573 label Biography information for Dr Rosena Allin-Khan

1111006

registered interest
date	10/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer: Screening
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to lower the mammogram screening age to help prevent breast cancer among younger women.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	243437
answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>There are currently no plans to lower the age of the National Health Service Breast Screening Programme, which offers all women between the ages of 50 to their 71<sup>st</sup> birthday the opportunity to be screened every three years for breast cancer.</p><p>The United Kingdom National Screening Committee awaits the publication of the Age Extension Trial which is looking at the benefits and harms of screening outside the recommended screening age. It is expected that the trial will report in 2026.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 12:02:04 answering member 4455 label Biography information for Seema Kennedy
tabling member	4079 label Biography information for Julian Sturdy

1111007

registered interest
date	10/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Breast Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reduce rates of breast cancer in women with BRCA 1 and 2 genes.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	243438
answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>NHS England commissions breast cancer screening services, according to the published national service specifications. The Breast Cancer Screening Programme service specification includes provision for the surveillance of high risk women for early detection of breast cancer (including those with the BRCA 1 and 2 genes) and timely referral to treatment as appropriate. Specifically, following an assessment by specialised services, and referral from a genetics or oncology service, high risk women who meet the eligibility criteria (as outlined in the published guidance) will be included in the screening programme at a younger age and according to different protocols to the general population.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 12:18:14 answering member 4455 label Biography information for Seema Kennedy
tabling member	4079 label Biography information for Julian Sturdy

1111101

registered interest
date	10/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent estimate his Department has made of the number of NHS prescriptions for medicine in which THC is the dominant ingredient.
tabling member constituency	Newcastle-under-Lyme
tabling member printed	Paul Farrelly
uin	243361
answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>The Department has made no estimate of the number of National Health Service prescriptions for cannabis-based products in which delta-9-tetrahydrocannabinol (THC) is the dominant ingredient.</p><p> </p><p>NHS England is using extant systems to monitor use of the newly rescheduled unlicensed cannabis-based products for medicinal use in England. In England, these systems monitor the number of items dispensed and associated costs in primary care and the volume of products used and associated cost in secondary care. NHS England Controlled Drug Accountable Officers are also collecting local intelligence in both the NHS and independent sector.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 11:49:19 answering member 4455 label Biography information for Seema Kennedy previous answer version 114110 answering member constituency South Ribble answering member printed Seema Kennedy answering member 4455 label Biography information for Seema Kennedy
tabling member	1436 label Biography information for Paul Farrelly

1111106

registered interest
date	10/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what advice has been issued to Clinical Commissioning Groups on the criteria for the prescription of medicinal cannabis.
tabling member constituency	Leigh
tabling member printed	Jo Platt
uin	243575
answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>The Chief Medical Officer and NHS England issued a letter on the 31 October 2018, and a supplementary letter on 20 November 2018, providing guidance to clinicians, the National Health Service and independent organisations following the rescheduling of cannabis-based products for medicinal use on 1 November 2018. This signposts interim guidance issued by the Royal College of Physicians, British Paediatric Neurology Association and Association of British Neurologists.</p><p> </p><p>Furthermore, the National Institute for Health and Care Excellence (NICE), has been commissioned to develop guidelines on the prescribing of cannabis-based medicinal products by October 2019. The guidance will focus on four indications: chronic pain, intractable nausea and vomiting, treatment-resistant epilepsy and spasticity. It will be based on the best available international evidence and produced using NICE’s world-renowned process for delivering such guidelines. This guidance will update and replace the interim guidance.</p><p> </p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 12:26:52 answering member 4455 label Biography information for Seema Kennedy
tabling member	4673 label Biography information for Jo Platt

1111176

registered interest
date	10/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Health Services: Tourism
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to support NHS trusts in areas with high volumes of tourists areas to help ensure the quality of treatment offered to residents.
tabling member constituency	Fylde
tabling member printed	Mark Menzies
uin	243404
answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>Clinical commissioning groups (CCGs) provide a wide range of health care services based on their local population needs using their knowledge and links to the community in which they work, and will use these plans to decide how to best use their budgets to make sure they are delivering high quality care to their patients.</p><p>While general practitioner practices do not receive any extra funding for patients that register temporarily with them, the costs are factored into practices baseline funding through a temporary patient adjustment. Where a practice has faced a significant increase or decrease in the numbers of temporary patients requiring treatment from it, NHS England may review the amount used for the temporary patient adjustment.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 14:29:13 answering member 4455 label Biography information for Seema Kennedy
tabling member	3998 label Biography information for Mark Menzies

1111184

registered interest
date	10/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Stem Cells: Transplant Surgery
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many (a) children and (b) adults were (i) recommended for a stem cell transplant and (ii) received such a transplant in each of the last five years; and what proportion of (A) children and (B) adults received the transplant to treat (1) acute myeloid leukaemia (2) acute lymphoblastic leukaemia, (3) Hodgkin lymphoma, (4) non-hodgkin lymphoma, (5) multiple myeloma and (6) non-malignant blood disorders.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	243386
answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>The data is not held in the format requested.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 12:15:01 answering member 4455 label Biography information for Seema Kennedy
tabling member	3960 label Biography information for Henry Smith

1110658

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Primary Care Networks: Staff
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people in each profession will constitute the 20,000 additional staff guaranteed to Primary Care Networks by 2023-24; and what criteria his Department uses to calculating the demand for those posts.
tabling member constituency	Cleethorpes
tabling member printed	Martin Vickers
uin	242795
answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>The new GP contract framework, published on 31 January 2019, set out plans for an ‘Additional Roles Reimbursement Scheme’ in Primary Care Networks. This will provide guaranteed funding for up to an estimated 20,000 additional staff by 2023/24 and will fund new roles for which there is both credible supply and demand. The funding available will be phased and will meet a recurrent 70% of costs for additional clinical pharmacists, physician associates, first contact physiotherapists and first contact community paramedics; and 100% of the costs of additional social prescribing link workers. The actual distribution of the workforce increase across these five roles will depend on the choices that individual networks make, working with their system partners, and taking in to account their existing workforce.</p><p> </p><p>From 2020/21, each network will be allotted a single combined maximum reimbursement sum, covering all five staff roles, offering Primary Care Networks flexibility to decide how many of each of the reimbursable staff they wish to engage, within their Additional Roles Sum.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 11:51:16 answering member 4455 label Biography information for Seema Kennedy
tabling member	3957 label Biography information for Martin Vickers

1110665

registered interest
date	09/04/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Patients: Transport
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how much funding his Department provided for transport for patients to attend appointments in each year for which information is available.
tabling member constituency	Upper Bann
tabling member printed	David Simpson
uin	242784
answer	answer is ministerial correction date of answer 17/04/2019 answer text <p>Neither the Department nor NHS England hold the information requested.</p><p>NHS England allocates funding to clinical commissioning groups (CCGs). Individual CCGs are responsible for commissioning local services, such as patient transport services, based on population need.</p><p>It is for local leaders working together with NHS England and NHS Improvement, to make the best use of the funding that has been allocated to them.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 17/04/2019 11:53:12 answering member 4455 label Biography information for Seema Kennedy
tabling member	1597 label Biography information for David Simpson